Women 60 and older who take antibiotics for more than a couple of months have a higher risk of all-cause and cardiovascular death, according to research presented March 22 at the American Heart Association’s Epidemiology and Prevention/Lifestyle and Cardiometabolic Health scientific sessions.
A new trial suggested patients exhibiting patent foramen ovale (PFO), who received a medical device to close the opening in the heart after a stroke, had better outcomes compared to patients who received only stroke-preventing medications.
More than a quarter million deaths from cardiovascular disease (CVD) each year in the United States can be attributed to historical lead exposure in people age 44 and older, according to new estimates published in The Lancet Public Health.
Avoiding frequent TV viewing, while increasing physical activity and controlling body weight, could help prevent venous thromboembolism (VTE), according to a study published Feb. 21 in the Journal of Thrombosis and Thrombolysis.
Patients with multiple sclerosis (MS) may have more cardiovascular dysfunction, including impaired biventricular function and reduced left atrial function, according to a new study published in Scientific Reports.
Endovascular coil embolization with second-generation hydrogel coils could decrease the rate of unfavorable outcomes in patients with small- and medium-sized intracranial aneurysms, according to a new study published in Stroke.
Already approved for robot-assisted PCI, Corindus Vascular Robotics’ CorPath GRX System is now cleared by the FDA for peripheral vascular interventions (PVIs). The system is the first to receive FDA clearance for both procedures.
The FDA on Feb. 15 announced Stryker’s Trevo Retriever clot-removal device can be used up to 24 hours after stroke onset, mirroring the American Heart Association and American Stroke Association’s recently updated guidelines expanding the window for mechanical thrombectomy from 6 to 24 hours.
A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).